About us

Noxilizer is an innovative & trusted sterilization solutions partner for the pharmaceutical, biotechnology, and medical device industries

The company

Noxilizer is an innovative and trusted sterilization solutions partner for the pharmaceutical, biotechnology, and medical device industries.

Noxilizer first commercialized its proprietary nitrogen dioxide (NO₂) based sterilization in 2012. This technology provides a safe, efficient, and scalable alternative to traditional sterilization methods, with several key advantages: ultra-low temperature (10–30°C), minimal pressure requirements, no/minimal cytotoxic residuals, and fast cycle times (6‒12 hours). This helps manufacturers protect product integrity while improving supply chain efficiency. NO₂ sterilization opens new avenues for innovation and has been shown to be particularly effective in the sterilization of prefilled syringes, drug-device combination products, and medical devices.

Noxilizer serves leading global pharmaceutical, biotech, and medical device companies through a range of offerings, including proprietary sterilization equipment, feasibility and validation studies, design and packaging consulting, and regulatory validation support. The company’s NO₂ sterilization platform is increasingly recognized as a validated, sustainable alternative to legacy technologies like ethylene oxide (EtO), especially as industry demand grows for safer and more environmentally sustainable and responsible methods.

Founded in 2004 and headquartered in Hanover, Maryland, it is conveniently located next to the Baltimore Washington International Airport and near global pharmaceutical companies and some of the leading contract manufacturing organizations (CMOs). In addition, the company has a global presence, with systems installed in Europe and Asia.

Driven by scientific excellence and a commitment to advancing healthcare manufacturing, Noxilizer continues to expand access to its terminal sterilization solutions worldwide—with a focus on delivering reliability, scalability, and performance that help bring next-generation medical products to market with confidence.